Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?

Polyglutamine (polyQ) diseases are a group of inherited neurodegenerative disorders caused by the expansion of the cytosine-adenine-guanine (CAG) repeat. This mutation encodes extended glutamine (Q) tract in the disease protein, resulting in the alteration of its conformation/physiological role and...

Descripción completa

Detalles Bibliográficos
Autores principales: Barros, Inês, Marcelo, Adriana, Silva, Teresa P., Barata, João, Rufino-Ramos, David, Pereira de Almeida, Luís, Miranda, Catarina O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cellular Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573388/
https://www.ncbi.nlm.nih.gov/pubmed/33132851
http://dx.doi.org/10.3389/fncel.2020.584277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573388/
https://www.ncbi.nlm.nih.gov/pubmed/33132851
http://dx.doi.org/10.3389/fncel.2020.584277

Ejemplares similares